Ophthalmology

Explore the complexities of Ophthalmology research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against Ophthalmology with flcube.com.

Jiangsu Nhwa Signs Exclusive Global Licensing Deal with Somnivera – Clinical‑Stage Sleep‑Disorder Asset Backed by Up to US$517.5 Million in Potential Value
CompanyDeals

Jiangsu Nhwa Signs Exclusive Global Licensing Deal with Somnivera – Clinical‑Stage Sleep‑Disorder Asset Backed by Up to US$517.5 Million in Potential Value

Jiangsu Nhwa Pharmaceutical Co., Ltd. (SHE: 002262) announced an exclusive licensing agreement with Somnivera, Inc., a U.S. biotechnology company, for an investigational clinical‑stage drug candidate targeting sleep disorders. Under the…

MindRank Signs Exclusive Greater China Commercialization Deal With Sunshine Mandi for MDR‑001 – AI‑Designed Oral GLP‑1 Candidate in Phase III for Obesity, Worth Up to RMB 1.75 Billion

MindRank Signs Exclusive Greater China Commercialization Deal With Sunshine Mandi for MDR‑001 – AI‑Designed Oral GLP‑1 Candidate in Phase III for Obesity, Worth Up to RMB 1.75 Billion

NMPA Approves Lilly's Jaypirca (Pirtobrutinib) as First‑Line Monotherapy for CLL/SLL – Non‑Covalent BTK Inhibitor Completes Line‑of‑Therapy Progression in China

NMPA Approves Lilly’s Jaypirca (Pirtobrutinib) as First‑Line Monotherapy for CLL/SLL – Non‑Covalent BTK Inhibitor Completes Line‑of‑Therapy Progression in China

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDeals

TowardPi Medical Partners with OCULUS Iberia to Introduce Advanced OCTA Technology to Spain

CompanyDrug

Ocumension Therapeutics and Shandong Boan Biotechnology File for Market Approval of Biosimilar Aflibercept in China

Company

Staidson Pharmaceutical Gets NMPA Green Light for Neurotrophic Keratitis Eye Drop Clinical Trial

CompanyDrug

Semaglutide Use Linked to Rare Eye Condition NAION in New Study

CompanyDeals

TowardPi Medical Secures RMB 200 Million in Series D Financing Led by Matrix Partners

CompanyDrug

StarryGene Initiates Phase I Clinical Trial for XMVA09 Gene Therapy in wAMD

CompanyDrug

Kanghong Pharmaceutical’s Lumitin Approved in Myanmar for Neovascular AMD Treatment

CompanyDrug

CGP’s GPN00884 Myopia Drug Enters Phase I Clinical Trial with First Patient Dosed

Show More